Remanded EB-3

EB-3 Remanded โ€” Medicine (2022): the Director's Notice of Intent to Revoke (NOIR) was

๐Ÿ“… 2022-06-29 ๐Ÿ‘ค Company ๐Ÿ“‚ Medicine

Decision Summary

The appeal was remanded because the Director's Notice of Intent to Revoke (NOIR) was deficient. The NOIR made conclusory observations about signature similarities without providing sufficient evidence or analysis, and the subsequent revocation decision failed to explain the specific grounds for the action as required by regulation.

Criteria Discussed

Signature Authenticity Notice Of Intent To Revoke (Noir) Procedure Good And Sufficient Cause For Revocation
๐Ÿ“„ Original decision (USCIS PDF)

Sign up free to download the original PDF

Research more EB-3 decisions on MeritDraft

Browse AAO decisions by visa type, outcome, and criteria discussed.

Browse Decisions โ†’